Hypomorphic PCNA mutation underlies a human DNA repair disorder
Emma L. Baple(University of Exeter), Andrew H. Crosby(University of Exeter), Roselyn Coblentz(Holmes Community College), Helen Chambers(University of Cambridge), Gaurav V. Harlalka(University of Exeter), Heather Fawcett(University of Sussex), Catherine Green(University of Oxford), Andrew P. Jackson(MRC Institute of Genetics and Molecular Medicine), Alan R. Lehmann(University of Sussex), Ajith Sreekantan-Nair(University of Exeter), Martina Muggenthaler(University of Exeter), Karin Wagner(Holmes Community College), Constance K. Stein(SUNY Upstate Medical University), Harold E. Cross(University of Arizona), Barry A. Chioza(University of Exeter), Yuka Nakazawa(Nagoya University), Sahar Mansour(St George's, University of London), A. Malcolm R. Taylor, James I. Last(University of Birmingham), Phillip Rich(St George's Hospital), Michael A. Patton(St George's Hospital), Tomoo Ogi(National Institute for Fusion Science)
Cited by 98
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection
|Nature Genetics|2006|673
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels
|Nature Genetics|2019|590